Wagner Wealth Management (South Carolina)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Wagner Wealth Management (South Carolina)’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-65	Closed	-$8.3K	–	301
2026 Q1	$8.3K	Hold	65	–	–	﹤0.01%	228
2025 Q4	$7.92K	Buy	+65	New	+$7.45K	﹤0.01%	216
2023 Q3	–	Sell	-106	Closed	-$8.82K	–	223
2023 Q2	$8.82K	Buy	106 +56	+112%	+$4.68K	﹤0.01%	182
2023 Q1	$3.81K	Hold	50	–	–	﹤0.01%	191
2022 Q4	$4.15K	Buy	+50	New	+$4.05K	﹤0.01%	202

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Wagner Wealth Management (South Carolina)'s XBI Position: Q2 2026 in Review

Wagner Wealth Management (South Carolina) sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2026, closing a stake of 65 shares — an estimated $8.3K sold.

Wagner Wealth Management (South Carolina) first reported a position in XBI in Q4 2022 and held it in 5 quarters. The position peaked at $8.82K in Q2 2023. 929 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Wagner Wealth Management (South Carolina) reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2026 after selling out during the quarter.
Wagner Wealth Management (South Carolina) sold 65 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $8.3K.
Wagner Wealth Management (South Carolina) first reported a position in State Street SPDR S&P Biotech ETF in Q4 2022 and held it in 5 quarters.
Wagner Wealth Management (South Carolina)'s State Street SPDR S&P Biotech ETF position peaked at $8.82K in Q2 2023.
929 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q2 2026, filed 24 Jul 2026.